James T.  Treace net worth and biography

James Treace Biography and Net Worth

James T. Treace has served as the chairman of our board of directors since June 2014. Mr. Treace has served as the Founder and President of J&A Group, LLC, a privately funded medical device investment and consulting company, since October 2000. Before that, from November 1999 to October 2000, Mr. Treace served as President of Medtronic Xomed, a subsidiary of Medtronic plc (NYSE: MDT). From April 1996 to November 1999, Mr. Treace served as Chief Executive Officer, President and Chairman of the board of directors of Xomed Surgical Products, Inc. (NASDAQ: XOMD), until it was acquired by Medtronic plc. From July 1993 to April 1996, Mr. Treace co-founded and served as the Chief Executive Officer and Chairman of the Board at TreBay Medical Corp., an orthopaedic and microsurgical device company. From September 1981 to July 1990, he served as President and Chief Executive Officer of Concept, Inc. (NASDAQ: CCPT), now known as Conmed Linvatec (NYSE: CNMD) and from June 1966 to September 1981 as Executive Vice President of Richards Medical, now known as Smith & Nephew (NYSE: SNN). Mr. Treace previously served as Chairman of the Boards of Kyphon, Inc. (NASDAQ: KYPH), now part of Medtronic plc, Wright Medical, acquired by Stryker Corporation (NYSE: SYK) in November 2020, American Medical Systems, Inc. (NASDAQ: AMMD), now part of Endo Pharmaceuticals (NASDAQ: ENDP), and Keystone Dental, Inc., a privately-held dental implant company.

What is James T. Treace's net worth?

The estimated net worth of James T. Treace is at least $10.77 million as of April 28th, 2023. Mr. Treace owns 871,441 shares of Treace Medical Concepts stock worth more than $10,771,011 as of March 28th. This net worth approximation does not reflect any other investments that Mr. Treace may own. Learn More about James T. Treace's net worth.

How do I contact James T. Treace?

The corporate mailing address for Mr. Treace and other Treace Medical Concepts executives is 203 FORT WADE RD. SUITE 150, PONTE VEDRA FL, 32081. Treace Medical Concepts can also be reached via phone at 904-373-5940 and via email at [email protected]. Learn More on James T. Treace's contact information.

Has James T. Treace been buying or selling shares of Treace Medical Concepts?

James T. Treace has not been actively trading shares of Treace Medical Concepts during the last quarter. Most recently, James T. Treace sold 10,000 shares of the business's stock in a transaction on Monday, May 1st. The shares were sold at an average price of $25.24, for a transaction totalling $252,400.00. Following the completion of the sale, the director now directly owns 861,441 shares of the company's stock, valued at $21,742,770.84. Learn More on James T. Treace's trading history.

Who are Treace Medical Concepts' active insiders?

Treace Medical Concepts' insider roster includes Sean Scanlan (SVP), Thomas Timbie (Director), James Treace (Director), John Treace (CEO), and John Treace (Director). Learn More on Treace Medical Concepts' active insiders.

Are insiders buying or selling shares of Treace Medical Concepts?

During the last twelve months, insiders at the sold shares 11 times. They sold a total of 1,300,798 shares worth more than $34,301,778.93. The most recent insider tranaction occured on June, 5th when Director F Barry Bays sold 1,042,318 shares worth more than $27,631,850.18. Insiders at Treace Medical Concepts own 28.7% of the company. Learn More about insider trades at Treace Medical Concepts.

Information on this page was last updated on 6/5/2023.

James T. Treace Insider Trading History at Treace Medical Concepts

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/1/2023Sell10,000$25.24$252,400.00861,441View SEC Filing Icon  
4/28/2023Sell40,000$25.01$1,000,400.00871,441View SEC Filing Icon  
2/28/2023Sell37,316$21.54$803,786.64974,125View SEC Filing Icon  
1/30/2023Sell38,071$23.20$883,247.201,023,370View SEC Filing Icon  
12/12/2022Sell25,000$24.18$604,500.001,061,441View SEC Filing Icon  
10/20/2022Sell8,742$23.02$201,240.841,086,441View SEC Filing Icon  
8/18/2022Sell34,046$19.09$649,938.141,186,441View SEC Filing Icon  
7/18/2022Sell13,961$16.09$224,632.491,256,680View SEC Filing Icon  
7/15/2022Sell8,456$16.18$136,818.081,270,641View SEC Filing Icon  
7/13/2022Sell4,544$16.13$73,294.721,281,897View SEC Filing Icon  
6/16/2022Sell20,809$13.58$282,586.221,315,632View SEC Filing Icon  
5/25/2022Sell30,313$15.35$465,304.551,356,128View SEC Filing Icon  
3/10/2022Sell2$19.20$38.40View SEC Filing Icon  
1/18/2022Sell42,937$19.46$835,554.02View SEC Filing Icon  
12/27/2021Sell6,437$17.46$112,390.02View SEC Filing Icon  
12/22/2021Sell23,390$16.28$380,789.20View SEC Filing Icon  
12/20/2021Sell16,119$15.70$253,068.30View SEC Filing Icon  
12/15/2021Sell75,000$16.06$1,204,500.00View SEC Filing Icon  
11/24/2021Sell17,000$17.83$303,110.00View SEC Filing Icon  
11/22/2021Sell16,000$18.52$296,320.00View SEC Filing Icon  
11/17/2021Sell25,000$20.33$508,250.00View SEC Filing Icon  
11/15/2021Sell25,000$20.63$515,750.00View SEC Filing Icon  
See Full Table

James T. Treace Buying and Selling Activity at Treace Medical Concepts

This chart shows James T Treace's buying and selling at Treace Medical Concepts by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Treace Medical Concepts Company Overview

Treace Medical Concepts logo
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Read More

Today's Range

Now: $13.05
Low: $12.41
High: $13.20

50 Day Range

MA: $13.55
Low: $11.48
High: $15.86

2 Week Range

Now: $13.05
Low: $5.27
High: $27.97

Volume

345,502 shs

Average Volume

524,016 shs

Market Capitalization

$805.97 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.28